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wounds have been associated with emergence of mupirocin-resistant 
s t r a i n s  of MRSA, which are increasing in kquency in some geo- 
graphic areas. Screening high-risk patients at the time of admission 
may be cost-effective in areas where MRSA is uncommon. Con- 
tinued efforts to control MRSA are warranted since poor control 
promotes fiequent use of vancomycin, which favors emergence of 
vancomycin-resistant enterococci. New agents with activity against 
MRSA have been marketed or are under development, but van- 
comycin remains the drug of choice for treatment of serious MRSA 
infections in many areas. 
Extensive Geographic Spread of 
Multidnrg-Resistant (MDR) Clones of MRSA 
H. de Lencastre. I T Q B / U N L ,  Oeiras, Portugaf, Rockefeller University, 
Nk: N1: USA 
One of the most striking findings to emerge liom the use of molec- 
ular fingerprinting techniques on meducih-resistant Staphylococcuz 
aureus (MRSA) is the extensive geographic spread of several unique 
MDR clones. I shall describe findmgs obtained through several re- 
cent and ongoing studies conducted in a number of countries by the 
international surveillance network CEM/NET. Collaborative s t u d e s  
with colleagues in B d  and in several southern and eastern Euro- 
pean countries have led to the identification of 3 unique epidemic 
MRSA clones each characterized by a combination of molecuar fin- 
gerprints and antibiotype which have acquired massive geographic 
spread the Brazilian epidemic clone was recovered liom hospitals 
separated by over 4000 km liom one another, and most recently in 
Portugal; the Iberian epidemic clone was recovered in hospitals in 
Portugal, Spain, as well as in Rome, Glasgow, Moscow, and most re- 
cently in New York City Yet another unique MDR clone of MRSA 
was found extensively spread in hospitals in 8 Hungarian cities. The 
usefulness of molecular fingerprinting techniques in outbreak inves- 
tigations will be documented. Using the experience of CEM/NET, 
data will also be provided for the efficacy and cost of operation of 
surveillance networks that use molecular fingerprinting techniques. 
Tracking Catheter-Related Infections by 
Coagulase-Negative Staphylococci Using 
Molecular Techniques 
A.M. Dominguez. E 
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15591 The importance of rapid bacteriological diagnosis 
in patient-care decision making 
A. Andremont. Groupe Hospitalin Bicht-Claude Bernard, Paris, France 
So far, except for duect examination of clinical specimens, the bacte- 
riologists had the reputation to be slow in term of providmg definite 
idenhfication and antibiotic susceptibihty testing of microorganisms, 
thus leadmg to the development of the art of empiric therapy. This 
was particularly true for mycobacteriological results. Obviously we 
are at a turning point. The arrival of molecular engineering in clin- 
ical practice together with computerization of results in most labo- 
ratory has dramatically changed the speed at whch microbiologists 
can provide meaningful clinical results. This has two kinds of im- 
plications. First, we have to evaluate what precise changes this will 
have in term of clinical decision making and patient outcome; sec- 
ond, we have to evaluate the economical terms associated with these 
changes both on the laboratory side where some costs wdl undoubt- 
edly increase and on the clinical side where quicker bgnos i s  will 
often be associated with a reduction of hospital stay and of the asso- 
ciated costs. Once again, technological developments will oblige us 
to change our practice and to transform some of our best established 
routines of thinking. Vaste programme ... 
Increased need for the rapid diagnosis and 
suceptibilii testing of M. tuberculosis 
E Portaels, J.C. Palomino, H. Traore, W Mijs, G. James, 
R. Rossau. Prince Leopold Imt. cf Tropical Medicine Microbiology Dept. 
Nationalesfmat 155, Anwrp.cn, Belgium 
The reemergence of tuberculosis (TB) in conjunction with the in- 
creasing number of multi-drug resistant strains of Mycobacten'um tu- 
berculosis has increased the need for rapid diagnostic and susceptibllity 
testing methods. 
During the last years several approaches have been developed to 
this end, involving culture methods as well as molecular biology 
techniques; among them the Mycobacteria Growth Indicator Tube 
(MGIT) has shown promise as a rapid detection method of my- 
cobacterial growth and more recently as a drug susceptibihty testing 
method as has been shown in comparative studies with the propor- 
tion method and the BACTEC system where it has shown high 
degrees of sensitivity and specificity for rifampicin and isoniazide. 
Other studies have evaluated the system with streptomycin, etham- 
butol and ofloxacin showing a very good agreement with the pro- 
portion method, results being obtained on an average of 5 days 
compared to 16 days with the proportion method. 
We also have developed a reverse hybridization based line probe 
assay (INNO-LIPA Rif TB) for the rapid detection of M .  tuber- 
culosis complex and resistance to rifampicin. The test can be used 
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directly on sputum specimens or on clinical isolates, and the results 
are available within 2 days. 
In conclusion the MGIT method is rapid and simple to perform 
and can be used for all antituberculous drugs. It requires no expen- 
sive equipment which makes it appropriate for s m a l l  laboratories in 
developing countries where the incidence of TB is high. 
The INNO-LIPA R f  TB test is another rapid and reliable tool 
for the diagnosis of TB and rifampicine resistance. It can be used im- 
medntely on sputum specimens transported in alcohol to a reference 
laboratory when PCR can not be performed locally. 
Tailon'ng the Choice of Different Blood Culture 
Media to Meet the Needs of Clinicians 
G. Fadda. Ist. di Minobiologia, Universitd Cattolica del Sam Cuore, 
Rome, M y  
Actual generation of blood culture systems offers the opportunity 
of rapid results to clinicians and a range of media that can be used 
to tailor dngnostic protocols related to dinical needs. The isolation 
of spechc pathogens f b m  blood cultures may be associated with 
very specific situations. The dSerent blood culture media contain 
reagents and growth factors to improve the selective detection of 
microorganisms, thus enabling the use of proper sets of media to 
match c h c a l  expectations. 
It has been widely demonstrated that the presence of antibiotic 
removal devices, such as resins, in the broth increases the recovery of 
bacteria fiom blood cultures of patients under drug therapy and is 
also helpful in monitoring the effectiveness of treatment, especially 
for those bacteria with a high risk of emergent resistance. Pediatric 
patients represent a very particular population: our experience shows 
that the use of a specific medium for children does not reduce the 
sensitivity of the system and allows to inoculate low amounts of 
blood (0.1 to 3.0 ml) and to recover some si&icant pediatric bac- 
teria such as, for example, Streptocorn agaiactiae. Specific mema have 
also been formulated to support and reveal growth of mycobacteria 
and fungi h m  blood. We are currently using these media, which 
ensure the detection of these organism for their selective proper- 
ties. In our experience, the adopted formulae of the fungal and 
mycobacterial media enhance the growth of these organism with a 
considerable reduction in the average time-to-detection. 
Conclusions: Often the clinical findmgs are not specific to indi- 
cate a selection of media, but epidemiological monitoring of isolates 
for each deparhnent can help in conmlling the efficiency of proto- 
cols. In our experience, the clinical impact of tailoring the choice of 
a e r e n t  blood culture media is positive and should result in better 
patient care and lower costs. 
miniaturized method providng identification of fIequently isolated 
aerobic catalase-positive and -negative Gram positive bacteria indud- 
ing staphylococci, streptococci, coryneforme bacteria, lactobad 
and bacilli within 4 hours. The advantage of the Crystal in com- 
parison to existing commercial micro-identification systems is the 
use of a slngle panel for the whole range of cknically relevant Gram 
positive bacteria. Another advantage is reduced hands-on time for 
panel inoculation, more rapid result readmg since no addition of 
reagents is required, and the overall ease of use of the system. 
Together with rapid susceptibility testing the same-day bacterial 
identification will have a major impact on the care and outcome of 
hosp ihed  patients with infection. Additionally, t h ~ ~  will improve 
cost-effectiveness in medical microbiology laboratories. 
Is63( Clinical Value of Rapid Results in Micmbiology - 
The American Experience 
P. Murray. Warhington University School dMedicine, Saint Louis, MO, 
USA 
bdical changes in the US health care system has had profound 
effects on laboratory medicine. An emphasis of out-patient dngnos- 
tic work, decreased length of hospitalization, and rapid turn-around 
times for tests has refined the workfiow and selection of testing pro- 
cedures for c h c a l  microbiology laboratories. Modifications of test 
selection have been seen in methods for microbial detection, micro- 
bial identification, and antimicrobial susceptibility testing. Improved 
microbial detection methods include the use of molecular probes 
(e.g., for mycobacteria, viruses), immunoassays (e.g., C. dtjiale, Gi- 
ardia, Entamoeba), direct biochemical assays (e.g., H. pylon urease 
test), and automated instruments (e.g., blood culture, mycobacte- 
rial culture). Improvements in microbial identification include use 
of probes (e.g., for many bacteria, fungi, viruses) and biochemical 
tests measuring preformed enzymes (e.g., Stnphylococcus, Smptococ- 
rus, iVeissm'a/Haemophiius, enteric gram-negative bacilli, anaerobes). 
Rapid antimicrobd susceptibility testing is acheved using 4-7 hour 
same day systems with novel indcators of bacterial p w t h .  The im- 
pact of these changes on laboratory and c h c a l  practices will be 
discussed. 
Susceptibility testing of yeasts 
Antifungal Susceptibilii Testing: New NCCLS 
interpretive Guidelines 
J. Rex. University of EXAS Medical School, Houston, Taus, USA 
Is62) Clinical Value of BBL Crystal Gram Positive 
Testing 
H.K. Geiss, H. von Baum, H.-G. Sonntag. Institute ofHygiene, 
University ofHeidelbeq, I h F  324, 69120 Heide!bq, Germany 
Cost containment in medical microbiology laboratories is becom- 
ing increasingly important. In contrast to clinical chemistry, rapid 
methods and automation in microbiology is far h m  being generally 
accepted. 
Regarding rapid methods, speed is just one of the three factors 
whch should direct the provision of microbiology services. Addi- 
tionally, results obtained by rapid methods in diagnostic laboratories 
must be accurate, clinically relevant, and generated and transmit- 
ted to the chician quickly enough to be meaningfd for the better 
management of the patient. 
The BBL Crystal Fbpid Gram Positive ID System is an advanced 
A reproducible broth-based method for antifungal susceptibility test- 
ing (M27) has been developed by the NCCLS in collaboration with 
many laboratories. Standardizing factors such as inoculum, incuba- 
tion time and temperature, medium, test format, and endpoint de- 
termination, has reduced inter-laboratory variability in MIC results 
h m  up to 50,000-fold (seen in early work) to 2-fold, thus providing 
a cornerstone for comparative studies. The method will shortly be 
released as M27-A ("A" for approved). 
Once a reproducible method is available, developing and d- 
dating interpretive breakpoints is the next task. For fluconazole, 
large datasets correlating M27 MIC with outcome are adable  
for OPC (mostly in AIDS patients) and candidemia (mostly in 
non-neutropenic patients). For itraconazole, such datasets are a d -  
able only for OPC. Based on analyses of these datasets, breakpoints 
have been proposed vs. isolates of Condida (Table). The familiar (S) 
and (R) categories are used, but the new S-DD category (Suscep- 
